References
- 1. J. G. Hardman, L. E. Limbird and A. G. Gilman, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th ed., McGraw-Hill, New York, 2001, 1011–1021.
- 2. F. Belal, S. Al-Shaboury and A. Al-Tamrah, Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative, J. Pharm. Biomed. Anal.30 (2002) 1191–1196; https://doi.org/10.1016/s0731-7085(02)00471-5
- 3. H. Basan and S. Yarımkaya, A novel solid-phase extraction-spectrofluorimetric method for the direct determination of atenolol in human urine, Luminescence29 (2013) 225–229; https://doi.org/10.1002/bio.2532
- 4. A. Bavili-Tabrizi, F. Bahrami and H. Badrouj, A very simple and sensitive spectrofluorimetric method based on the oxidation with cerium(IV) for the determination of four different drugs in their pharmaceutical formulations, Pharm. Sci.23 (2017) 50–58; https://doi.org/10.15171/ps.2017.08
- 5. Y. Jiang, N. N. Horimoto, K. Imura, H. Okamoto, K. Matsui and R. Shigemoto, Bioimaging with two-photon-induced luminescence from triangular nanoplates and nanoparticle aggregates of gold, Adv. Mat.21 (2009) 2309–2313; https://doi.org/10.1002/adma.200802312
- 6. A. D. McFarland, C. L. Haynes, C. A. Mirkin, R. P. V. Duyne and H. A. Godwin, Color my nanoworld, J. Chem. Ed. 81 (2004) 544A–544B; https://doi.org/10.1021/ed081p544a
- 7. O. Stern and M. Volmer, Decay of fluorescence, J. Röntgen Soc.15 (1919) 133–133; https://doi.org/10.1259/lrs.1919.0087
- 8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), Current Step 4 version, November 2005; https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1_Guideline.pdf; last access date Dec 11, 2017.
- 9. K. G. Thomas, B. I. Ipe and P. K. Sudeep, Photochemistry of chromophore-functionalized gold nanoparticles, Pure Appl. Chem.74 (2002) 1731–1738; https://doi.org/10.1351/pac200274091731
- 10. V. Amendola, G. A. Rizzi, S. Polizzi and M. Meneghetti, Synthesis of gold nanoparticles by laser ablation in toluene: quenching and recovery of the surface plasmon absorption, J. Phys. Chem. B109 (2005) 23125–23128; https://doi.org/10.1021/jp055783v
- 11. K. Wagers, T. Chui and S. Adem, Effect of pH on the stability of gold nanoparticles and their application for melamine detection in infant formula, IOSR J. Appl. Chem.7 (2014) 15–20; https://doi.org/10.9790/5736-07821520
- 12. R. Pamies, J. G. H. Cifre, V. F. Espín, M. Collado-González, F. G. D. Baños and J. G. de la Torre, Aggregation behaviour of gold nanoparticles in saline aqueous media, J. Nanopart. Res.16 (2014) Article ID 2376 (11 pages); https://doi.org/10.1007/s11051-014-2376-4
- 13. J. Lim, N.-E. Lee, E. Lee and S. Yoon, Surface modification of citrate-capped gold nanoparticles using CTAB micelles, Bull. Kor. Chem. Soc.35 (2014) 2567–2569; https://doi.org10.5012/bkcs.2014.35.8.25674
- 14. A. M. El-Didamony and M. A. Moustafa, Direct spectrophotometric determination of atenolol and timolol anti-hypertensive drugs, Int. J. Pharm. Pharm. Sci.9 (2017) 47–53; https://doi.org/10.22159/ijpps.2017v9i3.16198
- 15. I. E. H. Elgailani and T. H. Alghamdi, Development of spectrophotometric method for the determination of atenolol in Normoten drug, Int. J. Chem.9 (2017) 58–64; https://doi.org/0.5539/ijc.v9n1p58